Basic & Translational Research
Basic & translational research at University of Maryland links fundamental neuroscience research to clinical applications. Laboratory research explores molecular mechanisms and techniques in cerebral edema, cancer therapeutic delivery, neuronal activation regulation, and neuro-regeneration.
Efforts are led by Dr. J. Marc Simard, Dr. Graeme Woodworth, Dr. Anthony Kim, Dr. Alex Ksendzovsky, and Dr. Xiaofeng Jia in collaboration with the Center for Shock, Trauma and Anesthesiology Research (STAR) and the Greenbaum Comprehensive Cancer Center.
Clinical Research
The Department of Neurosurgery participates in multi- and single-center clinical trials for the management of stroke, subarachnoid hemorrhage, intracerebral and intraventricular hemorrhage, traumatic brain injury, spinal cord injury and focused ultrasound in treatment for essential tremor, Parkinson's disease, neuropathic pain, and glioblastoma.
View a list of our active clinical trials and our grant funding.
Translational Therapeutics Research Group
TTRG is a multi-disciplinary team of clinicians, engineers, and cancer biologists actively working together to solve life-limiting treatment challenges in the neuroscience and cancer fields.

Graeme Woodworth, MD, FACS
Director, Translational Therapeutics Research GroupShort blurb
Research Interests: keyword, keyword, keyword

Jeffrey Winkles, PhD
Co-Director, Translational Therapeutics Research GroupShort blurb
Research Interests: keyword, keyword, keyword

Anthony Kim, PhD
Co-Director, Translational Therapeutics Research GroupShort blurb
Research Interests: keyword, keyword, keyword